| ClinicalTrials.gov Identifier: |
NCT01252940 |
| Brief Title: |
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF |
|
|
First Submitted : |
December 1, 2010 |
|
First Submitted that Met QC Criteria : |
December 2, 2010 |
|
First Posted : |
December 3, 2010
(Estimate)
|
|
|
Results First Submitted : |
March 8, 2013 |
|
Results First Submitted that Met QC Criteria : |
March 8, 2013 |
|
Results First Posted : |
April 19, 2013
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
October 27, 2015 |
|
Last Update Posted : |
December 4, 2015
(Estimate)
|
|
